885 related articles for article (PubMed ID: 17560460)
1. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
2. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
3. Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients.
Taheri M; Mahjoubi F; Omranipour R
Genet Mol Res; 2010 Jan; 9(1):34-40. PubMed ID: 20082268
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
Drozdzik M; Mysliwiec K; Lewinska-Chelstowska M; Banach J; Drozdzik A; Grabarek J
J Clin Periodontol; 2004 Sep; 31(9):758-63. PubMed ID: 15312098
[TBL] [Abstract][Full Text] [Related]
6. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.
Schwab M; Schaeffeler E; Marx C; Fromm MF; Kaskas B; Metzler J; Stange E; Herfarth H; Schoelmerich J; Gregor M; Walker S; Cascorbi I; Roots I; Brinkmann U; Zanger UM; Eichelbaum M
Gastroenterology; 2003 Jan; 124(1):26-33. PubMed ID: 12512026
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
[TBL] [Abstract][Full Text] [Related]
8. Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population.
Jamroziak K; Balcerczak E; Młynarski W; Mirowski M; Robak T
Pol J Pharmacol; 2002; 54(5):495-500. PubMed ID: 12593536
[TBL] [Abstract][Full Text] [Related]
9. Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: impact on susceptibility and response to steroids.
Youssef DM; Attia TA; El-Shal AS; Abduelometty FA
Gene; 2013 Nov; 530(2):201-7. PubMed ID: 23994685
[TBL] [Abstract][Full Text] [Related]
10. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
[TBL] [Abstract][Full Text] [Related]
12. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.
Kafka A; Sauer G; Jaeger C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Int J Oncol; 2003 May; 22(5):1117-21. PubMed ID: 12684679
[TBL] [Abstract][Full Text] [Related]
14. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
[TBL] [Abstract][Full Text] [Related]
15. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells.
Calado RT; Falcão RP; Garcia AB; Gabellini SM; Zago MA; Franco RF
Haematologica; 2002 Jun; 87(6):564-8. PubMed ID: 12031911
[TBL] [Abstract][Full Text] [Related]
16. A common polymorphism in CD40 Kozak sequence (-1C/T) is associated with acute coronary syndrome.
Tian C; Qin W; Li L; Zheng W; Qiu F
Biomed Pharmacother; 2010 Mar; 64(3):191-4. PubMed ID: 20137882
[TBL] [Abstract][Full Text] [Related]
17. Association between MDR1 C3435T polymorphism and risk of breast cancer.
Wang Z; Wang T; Bian J
Gene; 2013 Dec; 532(1):94-9. PubMed ID: 24070710
[TBL] [Abstract][Full Text] [Related]
18. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
[TBL] [Abstract][Full Text] [Related]
19. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
[TBL] [Abstract][Full Text] [Related]
20. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]